Aniva International launches the first supplement EYEASPIS Re-D dedicated to the management of Diabetic Retinopathy. As always remaining dedicated to its mission Aniva brings in the market the 3rd medical intervention dedicated to autoimmune and chronic diseases.
Leave a Comment